Synergistic Antitumor Effects on Drug-Resistant Breast Cancer of Paclitaxel/Lapatinib Composite Nanocrystals

Drug resistance presents serious difficulties for cancer treatment. A combination of paclitaxel (PTX) and lapatinib (LAPA) shows potentials in multiple drug resistant cancers in the clinic, but it is almost impossible to deliver these two drugs to the tumor at the same time with the best proportion...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jun, Lv, Feng-Mei, Wang, Dong-Li, Du, Jian-Liang, Guo, Hai-Yan, Chen, Hai-Ni, Zhao, Shou-Jin, Liu, Zhe-Peng, Liu, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036807/
https://www.ncbi.nlm.nih.gov/pubmed/32019194
http://dx.doi.org/10.3390/molecules25030604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036807/
https://www.ncbi.nlm.nih.gov/pubmed/32019194
http://dx.doi.org/10.3390/molecules25030604

Ejemplares similares